A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Care Dx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 187,700 shares of CDNA stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187,700
Previous 228,900 18.0%
Holding current value
$2.91 Million
Previous $2.75 Million 27.64%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $327,952 - $509,643
-41,200 Reduced 18.0%
187,700 $1.99 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $255,290 - $670,006
-52,100 Reduced 18.54%
228,900 $2.75 Million
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $856,800 - $1.38 Million
-122,400 Reduced 30.34%
281,000 $1.97 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $570,750 - $709,500
-75,000 Reduced 15.68%
403,400 $3.43 Million
Q1 2023

May 15, 2023

SELL
$8.83 - $17.61 $255,187 - $508,929
-28,900 Reduced 5.7%
478,400 $4.37 Million
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $907,392 - $1.67 Million
-83,400 Reduced 14.12%
507,300 $5.79 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $3.4 Million - $5.59 Million
211,700 Added 55.86%
590,700 $10.1 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $3.58 Million - $6.94 Million
174,800 Added 85.6%
379,000 $8.14 Million
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $81,751 - $135,140
-2,900 Reduced 1.4%
204,200 $7.55 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $1.36 Million - $2.43 Million
33,000 Added 18.95%
207,100 $9.42 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $2.15 Million - $3.35 Million
-36,400 Reduced 17.29%
174,100 $11 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $7.78 Million - $11.7 Million
-123,400 Reduced 36.96%
210,500 $19.3 Million
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $4.32 Million - $7.17 Million
75,000 Added 28.97%
333,900 $22.7 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $567,591 - $1.06 Million
13,700 Added 5.59%
258,900 $18.8 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $4.03 Million - $4.95 Million
130,500 Added 113.78%
245,200 $9.3 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $644,300 - $1.2 Million
-34,000 Reduced 22.86%
114,700 $4.06 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $1.8 Million - $3.65 Million
-129,200 Reduced 46.49%
148,700 $3.25 Million
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $6.31 Million - $9.32 Million
-328,100 Reduced 54.14%
277,900 $5.99 Million
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $626,939 - $1.25 Million
-31,300 Reduced 4.91%
606,000 $13.7 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $56,716 - $87,494
-2,200 Reduced 0.34%
637,300 $22.9 Million
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $2.01 Million - $3.57 Million
91,000 Added 16.59%
639,500 $20.2 Million
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $171,054 - $258,172
-8,600 Reduced 1.54%
548,500 $13.8 Million
Q3 2018

Nov 14, 2018

BUY
$12.1 - $28.85 $1.74 Million - $4.15 Million
143,900 Added 34.83%
557,100 $16.1 Million
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $2.86 Million - $5.7 Million
360,700 Added 687.05%
413,200 $5.06 Million
Q1 2018

May 15, 2018

BUY
$5.18 - $7.97 $197,876 - $304,454
38,200 Added 267.13%
52,500 $418,000
Q4 2017

Feb 14, 2018

BUY
$3.98 - $7.37 $56,914 - $105,391
14,300
14,300 $105,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $830M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.